Literature DB >> 16859699

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.

Corinne Pellieux1, Ellen Aasum, Terje S Larsen, Christophe Montessuit, Irène Papageorgiou, Thierry Pedrazzini, René Lerch.   

Abstract

Heart failure is associated with downregulation of the fatty acid oxidation pathway in the ventricular myocardium. Since angiotensin II plays a critical role in myocardial phenotypic changes associated with heart failure, we investigated the effect of chronic angiotensin II stimulation on the fatty acid oxidation pathway in transgenic (TG) mice with targeted overexpression of angiotensinogen in the myocardium (TG1306/1R mice). TG1306/R1 mice progressively developed left ventricular hypertrophy. After 12 months, approximately half of the mice exhibited signs of heart failure including increased lung weight index [>+2 SD of age-matched wild-type (WT) mice] and 5-fold increase of myocardial brain natriuretic peptide expression. Myocardial mRNA and protein expression of peroxisome proliferator-activated receptor alpha (PPARalpha) progressively decreased in both WT and TG1306/R1 mice during the 12 months observation period, but much more pronounced in TG1306/R1 mice. Concomitantly, mRNA expression of enzymes of fatty acid oxidation (medium-chain acyl CoA dehydrogenase, MCAD; carnitine palmitoyl transferase I, CPT-I) was reduced in TG1306/R1 compared with age-matched WT mice. However, protein expression of MCAD and CPT-I was decreased concomitantly only in TG mice with criteria of heart failure. Correspondingly, myocardial oxidation of palmitate, measured during ex vivo working heart perfusion, was reduced by 25% in TG1306/R1 mice with heart failure. These results demonstrate that angiotensin II-induced cardiac hypertrophy is associated with reduction of PPARalpha and of mRNA expression of enzymes of fatty acid metabolism relative to age-matched WT mice. However, both protein expression of fatty acid oxidation enzymes and the rate of fatty acid oxidation remain unchanged unless heart failure occurs, suggesting the involvement of posttranscriptional mechanisms in the metabolic changes associated with heart failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859699     DOI: 10.1016/j.yjmcc.2006.06.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  20 in total

Review 1.  Mitochondrial membrane transporters and metabolic switch in heart failure.

Authors:  Vikas Kumar; T R Santhosh Kumar; C C Kartha
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

2.  Ageing-related cardiomyocyte functional decline is sex and angiotensin II dependent.

Authors:  Kimberley M Mellor; Claire L Curl; Chanchal Chandramouli; Thierry Pedrazzini; Igor R Wendt; Lea M D Delbridge
Journal:  Age (Dordr)       Date:  2014-02-25

Review 3.  Cardiac nuclear receptors: architects of mitochondrial structure and function.

Authors:  Rick B Vega; Daniel P Kelly
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 4.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 5.  The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.

Authors:  Kristine M Wadosky; Monte S Willis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

6.  Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction.

Authors:  Fabrizio Montecucco; Inga Bauer; Vincent Braunersreuther; Santina Bruzzone; Alexander Akhmedov; Thomas F Lüscher; Timo Speer; Alessandro Poggi; Elena Mannino; Graziano Pelli; Katia Galan; Maria Bertolotto; Sébastien Lenglet; Anna Garuti; Christophe Montessuit; René Lerch; Corinne Pellieux; Nicolas Vuilleumier; Franco Dallegri; Jacqueline Mage; Carlos Sebastian; Raul Mostoslavsky; Angèle Gayet-Ageron; Franco Patrone; François Mach; Alessio Nencioni
Journal:  Antioxid Redox Signal       Date:  2012-05-14       Impact factor: 8.401

7.  Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure.

Authors:  Gabriele Fragasso
Journal:  Card Fail Rev       Date:  2016-05

8.  The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.

Authors:  Jessica E Rodríguez; Jie-Ying Liao; Jun He; Jonathan C Schisler; Christopher B Newgard; Doreen Drujan; David J Glass; C Brandon Frederick; Bryan C Yoder; David S Lalush; Cam Patterson; Monte S Willis
Journal:  Mol Cell Endocrinol       Date:  2015-06-25       Impact factor: 4.102

9.  Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload.

Authors:  David J Chess; Biao Lei; Brian D Hoit; Agnes M Azimzadeh; William C Stanley
Journal:  J Card Fail       Date:  2008-02       Impact factor: 5.712

10.  Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.

Authors:  Corinne Pellieux; Christophe Montessuit; Irène Papageorgiou; René Lerch
Journal:  Pflugers Arch       Date:  2007-07-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.